Home | About | RSS Feed | Contact and Publicity Guidelines | Comment Policy the Law, the Universe, and Everything 

Search


Concurring Opinions is a
general-interest legal blog
operated by Concurring
Opinions LLC, a Pennsylvania
Limited Liability Corporation.

jr_114_9780195367195_bnr

jr_114_9780195383768_bnr

advertise-here4


FC-CO(SS)

Our Podcast

Subscribe to Law Talk

law-rev-contents2.jpg


  • Posts by Author

  • Categories

  • Archives


  • Recent Comments

    • RJ on Ricci: Color-Blind Standards in a Race Conscious Society?

    • RJ on Ricci and Briscoe as Disparate Impact Cases

    • Mike Rich on Negligent Corpse Mishandling

    • anon on Privacy and Tattletales

    • orly lobel on At CELS, Hoping to Blog

    • harry brooks on Ricci: Color-Blind Standards in a Race Conscious Society?

    • RJ on Ricci: Color-Blind Standards in a Race Conscious Society?

    • Michael H Schneider on Negligent Corpse Mishandling

    • flood pictures on Public opinion on same-sex marriage

    • gtownstudent on And Justache For All at GW Law

    • AF on Ricci and Briscoe as Disparate Impact Cases

    • RJ on Ricci and Briscoe as Disparate Impact Cases

    • Maryland Conservatarian on Ricci: Color-Blind Standards in a Race Conscious Society?

    • Daniel S. Goldberg on Negligent Corpse Mishandling

    • PrometheeFeu on KSM on Trial

  •  

    Site Meter

Reefer Madness At The FDA

posted by Dan Filler

marijuana-leaf.jpgOne of the most troubling behaviors of the current administration is its repeated willingness to manipulate the distribution of empirical data with which it disagrees. From global warming to crime, the government seems more interested in promoting its policy preferences than transparently reporting the results of the research it performs or supports. The administration has a legitimate right to advocate for its positions. But if it wants to argue that marijuana ought to be illegal, as the FDA did last week in its Inter-Agency Advisory Regarding Claims That Smoked Marijuana Is A Medicine, it seems to me the better policy – both from an honesty and a credibility point of view – is to concede the facts that cut against you, and make your case anyway. In its press release last week, the FDA asserted that:

A past evaluation by several Department of Health and Human Services (HHS) agencies, including the Food and Drug Administration (FDA), Substance Abuse and Mental Health Services Administration (SAMHSA) and National Institute for Drug Abuse (NIDA), concluded that no sound scientific studies supported medical use of marijuana for treatment in the United States.

True as this may be, a 1999 review of studies by the National Institute of Medicine suggests that marijuana offers potential therapeutic value for pain relief, control of nausea and vomiting, and appetite stimulation. Also, it notes that “until a non-smoked, rapid-onset cannabanoid drug delivery system becomes available…there is no clear alternative” to smoking. Why can’t the administration concede the existence of this data review by another federal agency?

It seems to me that the administration is driven by a decision, ex ante, that marijuana ought to be illegal. If it were truly interested in investigating the utility of the drug, it wouldn’t make serious research into its value exceedingly difficult. So the federal government ignores data suggesting the value of marijuana. It makes it hard to generate more research on marijuana. And it is therefore able to rail against the many states that have legalized marijuana for medical purposes. There are reasons to believe that, if the government allowed the debate to flourish – by sharing data that does exist and promoting the production of new data – its position might become weaker. But if marijuana is in fact effective as a medicine, perhaps the FDA should legalize it. And if the government’s real argument is something other than efficacy – that it is very likely to be misued, for example, or that its increased availability will lead to a rise in DUI cases – then it should make that case instead.

In some respects, this approach to policy debate reminds me of an argument made by death penalty opponents who argue that the death penalty is bad policy because it is expensive. But why is it expensive? Because opponents litigate these cases very aggressively. There are many good reasons why some people may oppose the death penalty. But it seems to me that when the people complaining about the cost of capital punishment are the people generating this expense, one should at least be skeptical. I’m not denying that the expense argument might mask a a deeper claim: perhaps these cases are so expensive, and require so many appeals, because the state fails to provide excellent counsel in the first instance. But if this is true, wouldn’t a more logical solution to the cost problem be a requirement that states spend money on quality counsel up front, to save in the long haul? In the end, the real claim underneath cost is fairness: the quality of a person’s lawyer should not determine whether he receives a death sentence. That may not “sell” as well to certain voters, but it is the more honest argument.

As for reefer, when government is making the arguments, I think we have a right to expect honesty. The FDA’s dubious pronouncement appears driven primarily by the administration’s emotional hatred of marijuana. Personally, I’d prefer FDA decisions to be grounded in evidence-based research rather than simply madness.


 April 24, 2006 at 12:41 am   Posted in: Administrative Announcements, Criminal Law, Empirical Analysis of Law, Politics   Print This Post Print This Post

Responses (6)

  1. John Armstrong - April 24, 2006 at 10:53 am

    I’ve said it before and I’ll say it again: the largest ideological divide in this country is one of epistemology — between the experimentalists and the gnostics. The experimentalists believe that observed events reflect reality and construct their realities from observations, while the gnostics construct their realities from fundamental points of faith and disregard or discredit observations which disagree with those points.

    As an example, the 2004 poll showing that Kerry supporters were generally accurate about Kerry’s positions while Bush supporters were generally inaccurate about his. Some try to spin this as an indictment of Bush voters’ attention, but what I think it clearly shows is that they have started with the point “Bush (or Republican) is good”, added their intuition that “labor and environmental standards in trade agreements are good” (or the US being part of the Comprehensive Test Ban Treaty, the International Criminal Court, the treaty banning land mines, or the Kyoto Treaty on global warming; or…) and concluded that Bush was also in favor of those points, despite what observations and explicit statements show.

    In this case, the gnostics in the FDA have already taken as given that marijuana is categorically bad, and so that is the Truth to them, despite what experimental observations may or may not show. You’re trying to argue as an experimentalist that these studies have any weight at all to compare with the fundamental point of faith. You’re not going to convince anyone to change their ways, because the whole notion of epistemology underlying your well-reasoned post is flawed in their estimation.

  2. Liz L - April 24, 2006 at 11:05 am

    Professor Filler- I am glad you are addressing this issue; I wanted to discuss marijuana in the context of Profsesor Anderson’s “Drunk at Duke” posting. I would argue that marijuana is the most benign of any illegal drug, safer even (both health wise and external risk wise) than alcohol. As you point out, this Administration continuously twists data unfavorable to its Mission, thus clouding the debate on issues such as the legalization of pot. Aside from the theraputic benefits to marijuana, there are economic reasons for legalization. First, tax revenue from its legalized sale would be staggering. Second, the costs of prosecution and incarceration of pot smokers would drop. Check out “Reefer Madness” by Eric Scholosser. It’s all in there.

  3. Liz L - April 24, 2006 at 11:08 am

    That’s Eric Schlosser. I apologize.

  4. Alex Geisinger - April 24, 2006 at 11:36 am

    Dan,

    Thanks for posting on this issue. I take the earlier point on experimentalism versus gnosticism but wonder whether the timing suggests something else.

    As we gear up for another election cycle, faith-based groups are starting again to bang the drum on homosexual unions (see the April 24th edition of the New York Times reporting on 50 religious leaders signing a petition for a constitutional amendment banning same-sex marriages) and I expect legalization of marijuana may be the latest entry in the “culture” wars. Currently about 11 states allow medical use of marijuana, including California, Colorado, Nevada, Oregon and Washington. Some midwestern states (Illinois and Wisconsin) are reported to be considering laws allowing the medical use of marijuana as well. While this type of issue doesn’t necessarily resonate with social conservatives in the way that Christian issues may, it nevertheless may impact the views of many conservatives and, perhaps, even some soccer moms. In a year of potentially-close elections, mary jane may be just what the doctor ordered (for republicans, at least)!!!

  5. Maryland Conservatarian - April 24, 2006 at 3:45 pm

    “Why can’t the administration concede the existence of this data review by another federal agency?’

    well, actually that wasn’t another federal agency that did the review – yes, the study was done at the behest of the ONDCP but it was the Institute of Medicine which did the study. IOM is part of the National Academy of Sciences which isn’t a federal agency.

    That said, I agree that the federal government should allow the states to set their own policy on this issue…as well as on most matters. That’s the problem with an overarching federal government – social conservatives can co-opt it to put forth their own agenda….insert ‘petard’ comment here…

  6. gloster - July 2, 2008 at 9:23 am

    It is well known in the drug policy field that eleven states reduced the criminal sanctions associated with possession of small amounts of marijuana.

    gloster

    Addiction Recovery Colorado

    Addiction Recovery Colorado

Leave a Reply

*
To prove you're a person (not a spam script), type the security word shown in the picture. Click on the picture to hear an audio file of the word.
Click to hear an audio file of the anti-spam word


  • « Previous post
  • Next post »

Authors

Daniel J. Solove

Website
Understanding Privacy

Kaimipono Wenger

Website
SSRN Page

Dave Hoffman

Website
SSRN Page

Nate Oman

Website
SSRN Page

Frank Pasquale

Website
SSRN Page

Deven Desai

Website
SSRN Page

Danielle Citron

Website
SSRN Page

Lawrence Cunningham

Website
SSRN Page

Sarah Waldeck

Website
SSRN Page

Jaya Ramji-Nogales

Website
SSRN Page

Solangel Maldonado

Website
SSRN Page

Gerard Magliocca

Website
SSRN Page


Guests

Rachel Godsil
Alex Kreit
Anita Krishnakumar
Matthew Sag
Michael Zimmer






Previous Guests

Michael Abramowicz
Michelle Adams
Robert Ahdieh
Michelle Anderson
Laura Appleman
Ann Bartow
Francesca Bignami
Jeremy Blumenthal
Kathleen Boozang
Bruce Boyden
Donald Braman
Al Brophy
Neil H. Buchanan
Bill Burke-White
Scott Burris
Paul Butler
Naomi Cahn
Anupam Chander
Miriam Cherry
Jack Chin
Jennifer Collins
Allison Danner
Brannon Denning
Deven Desai
Mike Dimino
Mark Edwards
David Fagundes
Christine Haight Farley
Kim Ferzan
Dan Filler
Michael Froomkin
Amanda Frost
Timothy Glynn
Rachel Godsil
Eric Goldman
David Gray
Craig Green
Tristin Green
Jeffrey Harrison
Erica Hashimoto
Carissa Hessick
Laura Heymann
Robert Hillman
Christine Hurt
Darian Ibrahim
John Ip
Kevin Johnson
Dan Kahan
Brian Kalt
Sam Kamin
Michael Kang
Chimène Keitner
Orin Kerr
Nancy Kim
Heidi Kitrosser
Adam Kolber
Russell Korobkin
Anita S. Krishnakumar
Susan Kuo
Greg Lastowka
Sarah Lawsky
Erik Lillquist
Jeff Lipshaw
Jonathan Lipson
Jacqueline Lipton
Joseph Liu
Michael Madison
Solangel Maldonado
Jason Mazzone
Linda McClain
William McGeveran
Salil Mehra
Carrie Menkel-Meadow
Max Minzner
Scott Moss
Eric Muller
Jaya Ramji-Nogales
Helen Norton
Elizabeth Nowicki
Paul Ohm
Michael O'Shea
David Opderback
Kristen Osenga
Rafael Pardo
Marcy Peek
Eduardo Peñalver
Robert Percival
David Post
Shruti Rana
Geoffrey Rapp
Neil Richards
Lori Ringhand
Alice Ristroph
Susan Scafidi
Paul Secunda
Jonathan Siegel
Jessica Silbey
Peter Smith
Charles Sullivan
Rick Swedloff
Steph Tai
Andrew Taslitz
Robert Tsai
Jenia Turner
Steve Vladeck
Sarah Waldeck
Melissa Waters
Alfred Yen
David Zaring
Timothy Zick
Spencer Weber Waller
Howard Wasserman
Frank Wu
Corey Yung
Jonathan Zittrain

Blogroll

Above the Law
ACS Blog
Althouse
Balkinization
Becker-Posner Blog
BlackProf
BoingBoing
Chicago Law Faculty Blog
Conglomerate
CrimLaw
Crime & Federalism
CrimProf Blog
Crooked Timber
Discourse.net
Dorf on Law
Election Law
Emergent Chaos
The Faculty Lounge
Feminist Law Profs
43(B)log
Freakonomics Blog
Freedom to Tinker
Google Blogoscoped
How Appealing
Ideoblog
Info/Law
Instapundit.com
Juris Novus
Jurisdynamics
Law and Humanities Blog
Law and Letters
Law Librarian Blog
Legal Profession Blog
Legal Theory Blog
Legal Times Blog
Leiter Reports
Brian Leiter's Law School Reports
Lessig Blog
Madisonian Theory
Media Law Blog
Mirror of Justice
The Moderate Voice
National Security Advisors
Opinio Juris
Point of Law
PrawfsBlawg
ProfessorBainbridge.com
Property Prof Blog
Red Tape Chronicles
The Right Coast
Schneier on Security
SCOTUSBlog
Security Dilemmas
Sentencing Law and Policy
Simple Justice
Sivacracy.net
The Situationist
Susan Crawford
TalkLeft
Talking Points Memo
TaxProf Blog
Tech & Marketing Law
Truth on the Market
Volokh Conspiracy
WorkPlace Prof Blog
WSJ Law Blog
Wonkette
The Yin Blog


© Concurring Opinions

Powered by WordPress